No headlines found.
Abacus Life and Lorisco Life Announce Launch of PREADISAN to Improve Health Predictions
Globe Newswire (Mon, 19-Aug 8:00 AM ET)
Abacus Life Reports Second Quarter 2024 Results
Globe Newswire (Mon, 12-Aug 7:00 AM ET)
Abacus Life Announces Agreement to Acquire FCF Advisors
Globe Newswire (Wed, 7-Aug 4:05 PM ET)
Abacus Life Provides Preliminary Second Quarter 2024 Results
Globe Newswire (Thu, 18-Jul 4:15 PM ET)
Abacus Life Announces Agreement to Acquire Carlisle Management Company SCA
Globe Newswire (Thu, 18-Jul 4:05 PM ET)
Abacus Life Announces Closing of Public Offering of 11,500,000 Shares of Common Stock
Globe Newswire (Mon, 24-Jun 4:21 PM ET)
Abacus Life Announces Pricing of Public Offering of Common Stock
Globe Newswire (Thu, 20-Jun 9:20 PM ET)
Abacus Life Announces Proposed Public Offering of Common Stock
Globe Newswire (Thu, 13-Jun 4:05 PM ET)
Abacus Life - Warrant trades on the stock market under the symbol ABLLW.
As of September 6, 2024, ABLLW stock price declined to $1.40 with 16,717 million shares trading.
ABLLW has a beta of 0.68, meaning it tends to be less sensitive to market movements. ABLLW has a correlation of 0.01 to the broad based SPY ETF.
ABLLW has a market cap of $0.00. This is considered a Sub-Micro Cap stock.
ABLLW has outperformed the market in the last year with a price return of +197.6% while the SPY ETF gained +22.6%. ABLLW has also outperformed the stock market ETF in the last 3 month and 2 week periods returning +254.4% and -3.4%, respectively, while the SPY returned +1.4% and -3.9%, respectively.
ABLLW support price is $1.35 and resistance is $1.58 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that ABLLW stock will trade within this expected range on the day.